Executive record
Alpha ID: alpha:person:paul-rubin-m-d-bioaVersion: public-0As of: 2026-10-03
- Executive
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Dr. Rubin has served as Chief Medical Officer since May 2020, previously serving as EVP of Research and Development at miRagen Therapeutics and SVP of R&D and CMO at XOMA Ltd. He also previously served as CEO of Resolvyx Pharmaceuticals and President and CEO of Critical Therapeutics.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Current · dates not publishedChief Medical Officer · BioAge Labs, Inc.
- 2026 to end not publishedExecutive title: Chief Medical Officer · Organization not publishedBIOA DEF 14A executive officers
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
BIOA DEF 14A executive officers
sec filing · Source published: Apr 21, 2026 · Retrieved: May 15, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at BioAge Labs, Inc. · Claim reviewed: May 15, 2026
- Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 15, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026
Open source
sec def 14a · Source published: Apr 21, 2026 · Retrieved: Sep 6, 2026
Supports 1 claim
- Professional Role: Chief Medical Officer at BioAge Labs, Inc. · Claim reviewed: Sep 6, 2026
BIOA executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
- Executive company: Executive at BioAge Labs, Inc. · Claim reviewed: May 15, 2026
- Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 15, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope